10,000 results
·
392ms
·
Sources: EU EUDAMED, US FDA
Drexco Medical speculum vaginal cusco
Device
EU MDD
·
Eu Md Class 1
·G P S S.R.L. ·On the market·2 countries
drexco medical
Device
EU MDD
·
Eu Md Class 1
·G P S S.R.L. ·On the market·2 countries
Vis Activ Neo
Device
EU MDD
·
Eu Md Class 2b
·OPKO HEALTH SPAIN S.L.U.·On the market·1 country
drexo medical
Device
EU MDD
·
Eu Md Class 1
·G P S S.R.L. ·On the market·2 countries
URIMED B'BAGS
Device
EU MDD
·
Eu Md Class 1
·Tecnoclínic SA·On the market
TECNOCLINIC MEDICAL PRODUCTS
Device
EU MDD
·
Eu Md Class 1
·Tecnoclínic SA·On the market
TECNOCLINIC MEDICAL PRODUCTS
Device
EU MDD
·
Eu Md Class 1
·Tecnoclínic SA·On the market
TECNOCLINIC MEDICAL PRODUCTS
Device
EU MDD
·
Eu Md Class 1
·Tecnoclínic SA·On the market
TECNOCLINIC MEDICAL PRODUCTS
Device
EU MDD
·
Eu Md Class 1
·Tecnoclínic SA·On the market
TECNOCLINIC MEDICAL PRODUCTS
Device
EU MDD
·
Eu Md Class 1
·Tecnoclínic SA·On the market
TECNOCLINIC MEDICAL PRODUCTS
Device
EU MDD
·
Eu Md Class 1
·Tecnoclínic SA·On the market
TECNOCLINIC MEDICAL PRODUCTS
Device
EU MDD
·
Eu Md Class 1
·Tecnoclínic SA·On the market
Cyclosporine
FDA Pre-Market Approval
FDA Class 2
·EMIT 2000 CYCLOSPORINE SPECIFIC ASSAY
Test, Prostate Specific Antigen, Free, (Noncomplexed) To Distinguish Prostate Cancer From Benign Conditions
FDA Pre-Market Approval
FDA Class 3
·DIMENSION FPSA FLEX REAGENT CARTRIDGE
Test, Prostate Specific Antigen, Free, (Noncomplexed) To Distinguish Prostate Cancer From Benign Conditions
FDA Pre-Market Approval
FDA Class 3
·Dimension Vista FPSA Flex reagent cartridge (K6452)
Kit, Assay, Progesterone Receptor
FDA Pre-Market Approval
FDA Class 3
·RIANEN(TM) (3H) PROGESTIN RECEPTOR ASSAY KIT
Test, Prostate Specific Antigen, Free, (Noncomplexed) To Distinguish Prostate Cancer From Benign Conditions
FDA Pre-Market Approval
FDA Class 3
·Dimension FPSA Flex Reagent Cartridge
Lens, Contact (Polymethylmethacrylate)
FDA Pre-Market Approval
FDA Unclassified
·PARAPERM O2 CONTACT LENS CLEAR & BLUE
Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers
FDA Pre-Market Approval
FDA Class 2
·Dimension TPSA Flex reagent cartridge (RF451)
Test, Prostate Specific Antigen, Free, (Noncomplexed) To Distinguish Prostate Cancer From Benign Conditions
FDA Pre-Market Approval
FDA Class 3
·DIMENSION FPSA FLEX REAGENT CARTRIDGE AND DIMENSION VISTA FPSA FLEX REAGENT CARTRIDGE